| Patents for C07D 217 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems (11,865) |
|---|
| 03/15/2006 | EP1633731A2 Thiocarbamate inhibitors of alpha-4 integrins |
| 03/15/2006 | EP1633717A1 New p2x7 receptor antagonists and their use |
| 03/15/2006 | EP1633704A2 Intermediates useful in the synthesis of hiv-protease inhibitors and methods for preparing the same |
| 03/15/2006 | EP0997147B1 Amino acid derivatives |
| 03/15/2006 | CN1747935A Preparation of quinapril hydrochloride |
| 03/14/2006 | US7012081 Antiproliferative agents; skin disorders; vision defects; liver and kidney disorders |
| 03/09/2006 | WO2006026533A2 Methods of treatment of amyloidosis using ethanol cyclicamine derivatives aspartyl protease inhibitors |
| 03/09/2006 | WO2005113510B1 Dpp-iv inhibitors |
| 03/09/2006 | WO2005063239A9 3-(4-piperidine-1ylmethyl-phenyl)-propion acid-phenylamide-derivatives and related compounds used in the form of mch antagonists (melanine concentrating hormone) for treating eating disorders |
| 03/09/2006 | US20060052588 Novel nitrosation polymer in organic synthesis |
| 03/09/2006 | US20060052445 Diarylsulfones as 5-HT2A antagonists |
| 03/09/2006 | US20060052411 Immunosuppressants, analgesics, antiinflammatory agents |
| 03/09/2006 | US20060052315 Cb 1/cb 2 receptor ligands and their use in the treatment of pain |
| 03/09/2006 | CA2577392A1 Methods of treatment of amyloidosis using ethanol cyclicamine derivatives aspartyl protease inhibitors |
| 03/09/2006 | CA2576782A1 Methods of treatment of amyloidosis using substituted ethanolcyclicamine aspartyl protease inhibitors |
| 03/08/2006 | EP1632477A1 Benzamide derivative or salt thereof |
| 03/08/2006 | EP1631551A2 Isoquinoline derivatives and their use as gfat inhibitors |
| 03/08/2006 | EP1631542A1 Bicyclic compounds having bradykinin receptors affinity and pharmaceutical compositions thereof |
| 03/08/2006 | EP1387839B1 Process for the production of quinazolines |
| 03/08/2006 | EP1313721B1 Non-imidazole aryloxyalkylamines as h3 receptor ligands |
| 03/08/2006 | EP1276722B1 Naphthamidine urokinase inhibitors |
| 03/08/2006 | CN1745076A Malonamide derivatives as gamma-secretase inhibitors |
| 03/08/2006 | CN1745065A 4-oxo-3-(1-oxo-1h-isoquinolin-2-ylacetylamino)-pentanoic acid ester and amide derivatives and their use as aspartic specifity cysteine proteinase inhibitors |
| 03/08/2006 | CN1244577C 4-phenyl-peiperazinyl,-piperidinyl and -tetrahydropyridyl derivatives |
| 03/08/2006 | CN1244575C Sulfonyl alkylamido hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 03/08/2006 | CN1244561C Tetrahydroisoquinoline analogs useful as growth hormone secretagogues |
| 03/07/2006 | US7008951 Such as asthma or chronic obstructive pulmonary disease; mixture of a corticoid such as budesonide, fluticasone propionate or mometasone furoate and 5-(1-hydroxy-2-((5,6-diethylindan-2-yl)amino)ethyl)8-hydroxy-1,2-dihydroquinolin-2-one or its salt |
| 03/02/2006 | WO2006021964A2 Novel crystalline forms of nelfinavir mesylate |
| 03/02/2006 | WO2006021806A1 Arylsulphonylstilbene derivatives for treatment of insomnia and related conditions |
| 03/02/2006 | WO2006021805A1 Diarylsulfones as 5-ht2a antagonists |
| 03/02/2006 | WO2006021565A1 Novel substituted heteroaryloxy alkylamines and their use as monoamine neurotransmitter re-uptake inhibitors |
| 03/02/2006 | WO2005113542A3 N-cyclic sulfonamido inhibitors of gamma secretase |
| 03/02/2006 | CA2577837A1 Diarylsulfones as 5-ht2a antagonists |
| 03/02/2006 | CA2577752A1 Small molecule inhibitors of anti-apoptotic bcl-2 family members and the uses thereof |
| 03/01/2006 | EP1630159A1 5-HT7 receptor antagonists |
| 03/01/2006 | EP1630158A1 5-HT7 receptor antagonists |
| 03/01/2006 | EP1017382B1 Biarylalkanoic acids as cell adhesion inhibitors |
| 03/01/2006 | CN1741990A Arylalkylcarbamate derivatives production and use thereof in therapy |
| 03/01/2006 | CN1741986A Amide derivatives and their use as inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1 |
| 03/01/2006 | CN1740170A Prepn process of peptide HIV proteinase inhibitor |
| 02/23/2006 | WO2006018309A1 5-ht7 receptor antagonists |
| 02/23/2006 | WO2006018308A1 5-ht7 receptor antagonists |
| 02/23/2006 | WO2005077903A3 Melanin concentrating hormone receptor ligands: substituted tetrahydroisoquinoline analogues |
| 02/23/2006 | US20060040978 5-HT7 receptor antagonists |
| 02/23/2006 | US20060040977 N-[3-(3,4-Dihydro-1H-isoquinolin-2-yl)-propyl]-2-methyl-5-nitro-benzenesulfonamidehydrochloride; selective ligands of the 5-HT7 receptor; treating Central nervous system, pain, sleep disorder, shift worker syndrome, jet lag, depression, seasonal affective disorder, migraine, anxiety, psychosis |
| 02/23/2006 | US20060040974 Decahydroisoquinolinyl- hydroxyethylamine derivatives; human immunodeficiency virus (HIV) protease |
| 02/23/2006 | US20060040919 N-substituted-(dihydroisoquinoline or tetrahydro 2- or 3- benzazepine)-2-carbothioamides; blocking agents; asthma, chronic obstructive pulmonary disease, bronchiectasis, cystic fibrosis, bronchiolitis or bronchopulmonary dysplasia; coadministering with a beta 2-agonist, anticholinergic agent or corticoid |
| 02/23/2006 | CA2577060A1 Substituted benzofused heterocycles |
| 02/23/2006 | CA2575785A1 5-ht7 receptor antagonists |
| 02/23/2006 | CA2575771A1 5-ht7 receptor antagonists |
| 02/23/2006 | CA2573271A1 Aryl-and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin |
| 02/22/2006 | EP1406622B1 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 02/22/2006 | CN1738797A Substituted aryl thioureas and related compounds; inhibitors of viral replication |
| 02/22/2006 | CN1242994C Novel heterocyclic compound and medicinal use thereof |
| 02/22/2006 | CN1242993C Heterocycle derivatives and drugs |
| 02/21/2006 | CA2423825C New perindopril salt and pharmaceutical compounds containing it |
| 02/21/2006 | CA2239970C Process for preparing optically active compounds |
| 02/16/2006 | WO2006015870A1 Tetrahydro-naphthalene derivatives as glucocorticoid receptor modulators |
| 02/16/2006 | WO2006015859A1 Trifluoromethyl substituted benzamides as kinase inhibitors |
| 02/16/2006 | WO2005090287A3 Phenylethanolamine derivatives as beta-2 agonists |
| 02/16/2006 | US20060035934 Fused compounds that inhibit vanilloid subtype 1 (VR1) receptor |
| 02/16/2006 | US20060035897 Trifluoromethyl substituted benzamides as kinase inhibitors |
| 02/16/2006 | US20060035884 N-cyclic sulfonamido inhibitors of gamma secretase |
| 02/16/2006 | US20060035870 Carboxylic acid derivatives as IP antagonists |
| 02/16/2006 | CA2575316A1 Trifluoromethyl substituted benzamides as kinase inhibitors |
| 02/15/2006 | EP1624868A1 "(2-hydroxy-2-(4-hydroxy-3-hydoxymethylphenyl)-ethylamino)- propyl!phenyl derivatives as beta2 agonists |
| 02/15/2006 | EP1233743B1 Compositions for dyeing keratinous fibres containing 3-amino pyrazolo-[1,5-a]-pyridines, dyeing method, novel 3-amino pyrazolo-[1,5-a]-pyridines |
| 02/15/2006 | CN1733731A Tetra cyano-p-Benzodiquinone-dimethane charge transfer complex and its synthesis method |
| 02/15/2006 | CN1241909C Carboxylic acid derivatives as IP antagonists |
| 02/14/2006 | US6998408 6-5, 6-6, or 6-7 Heterobicycles as factor Xa inhibitors |
| 02/14/2006 | US6998401 Such as 2-(4-amino-2,3,5-trimethylphenoxy)-N-methyl-N-(4-piperidinyl)acetamide which has neuroprotective effects by inducing calcium binding proteins |
| 02/14/2006 | CA2363145C Oxamic acids and derivatives as thyroid receptor ligands |
| 02/14/2006 | CA2241094C Tri-substituted phenyl derivatives useful as pde iv inhibitors |
| 02/14/2006 | CA2241093C Tri-substituted phenyl derivatives useful as pde iv inhibitors |
| 02/09/2006 | WO2006014135A1 Novel piperidine derivatives as histamine h3 receptor ligands for treatment of depression |
| 02/09/2006 | US20060030618 Vanilloid receptor ligands and their use in treatments |
| 02/09/2006 | US20060030573 melanocortin-4 receptor (MC4-R) agonists such as (3R,5S)-N-(2-{2-[2-fluoro-4-(methyloxy)phenyl]ethyl}-1-oxo-1,2-dihydroisoquinolin-6-yl)-3,5-dimethyl-N'-[(1S,2S,3S,5R)-2,6,6-trimethylbicyclo[3.1.1]hept-3-yl]piperazine-1-carboximidamide, used for the treatment of obesity or diabetes |
| 02/09/2006 | US20060030565 Amide derivatives and nociceptin antagonists |
| 02/09/2006 | US20060030558 use as pain relievers, gastrointestinal disorders; 2-Amino-3-aryl-1-[3-((hetero)aryl)piperidin-1-yl]-propan-1-one compounds |
| 02/09/2006 | US20060030553 Cell adhesion inhibitors |
| 02/09/2006 | US20060030543 Multicyclic sulfonamide compounds as inhibitors of histone deacetylase for the treatment of disease |
| 02/09/2006 | CA2576109A1 Novel piperidine derivatives as histamine h3 receptor ligands for treatment of depression |
| 02/09/2006 | CA2574956A1 Heterocyclic acetophenone potentiators of metabotropic glutamate receptors |
| 02/08/2006 | EP1622869A1 Glyoxalase inhibitors |
| 02/08/2006 | EP1318978B1 N-acylsulfonamide apoptosis promoters |
| 02/08/2006 | CN1732146A Cycloalkyl inhibitors of potassium channel function |
| 02/07/2006 | US6995181 hyterocyclylaminomethyl- or aminocarbonyl-substituted 9,10-ethanoanthracenes or their aza derivatives; treating obesity, diabetes, inflammatory and immune disorders |
| 02/02/2006 | WO2006012374A1 Substituted aryl-amine derivatives and methods of use |
| 02/02/2006 | WO2005118540A3 Bicyclic, nitrogen-containing heterocycles as aromatase inhibitors |
| 02/02/2006 | WO2005115392A3 3-(4-heteroarylcyclohexylamino) cyclopentanecarboxamides as modulators of chemokine receptors |
| 02/02/2006 | DE102004031620A1 4-Trifluormethoxyphenoxybenzol-4`-sulfonsäuren, Verfahren zu ihrer Herstellung und Verwendung in Arzneimitteln 4-Trifluormethoxyphenoxybenzol-4`-sulfonic acids, process for their preparation and use in pharmaceuticals |
| 02/01/2006 | EP1621533A1 Preparation of fused polycyclic alkaloids by ring closure of azomethine ylides, novel compounds thereof and their use as chemotherapeutic agents |
| 02/01/2006 | EP1620102A2 3-(1-naphthyl)-2-cyanopropanoic acid derivatives as estrogen receptor ligands |
| 02/01/2006 | EP0901996B1 Process for producing optically active amines |
| 02/01/2006 | CN1729158A Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 02/01/2006 | CN1729157A Substituted amino phenylacetic acids, derivatives thereof, their preparation and their use as cyclooxygenase 2 (COX-2) inhibitors |
| 02/01/2006 | CN1727332A Compound in category of aryl methylamino dithio formic ether, preparation method and application |
| 02/01/2006 | CN1239485C Benzophenones as inhibitors of IL-1 beta and TNF-alpha |
| 01/31/2006 | US6992177 haptens comprising protease inhibitors such as succinimido-oxycarbonyl-ethylamino-glycyl-glycyl-glutaryl-aminomethyl-(pyr)saquinavir conjugates with hemocyanins, albumin or dextran, used to generate antibodies and immunogens to saquinavir; assays |
| 01/31/2006 | US6992084 Compounds and methods for modulating CXCR3 function |